Note: results can be filtered by year and/or keyword. To filter on year, select the appropriate year from the drop down menu. To filter on keyword, enter relevant term into open box, select appropriate keyword, and click "filter".
Submission to the Expert Committee on “Regulation of Newer TB drugs in India”, Ministry of Health & Family Welfare, January 2014
Last updated 6 March 2014
Four essential interventions to improve HIV treatment, save lives and reduce transmission Today, nearly ten million people are receiving antiretroviral therapy (ART) in developing countries, but with an estimated additional 18 million people1 eligible for treatment, the job is far from done. With the release of new ART guidelines in 2013,2 the World Health Organization (WHO) has laid out a clear benchmark for the quality of care that national treatment programmes, treatment providers and donors should strive to achieve.
Last updated 6 December 2013
Pricing for HIV viral load testing in low- and middle-income countries
Last updated 6 December 2013
The Open Source Fever Diagnostic Project The World Health Organization (WHO), as part of its broader efforts to address health R&D gaps for the poor, is conducting a process whereby member states will support "health R&D demonstration projects" aimed at developing health technologies (medicines, diagnostics, medical devices, vaccines, etc.) for diseases that disproportionately affect developing countries and for which identified R&D gaps remain unaddressed due to market failures.
Last updated 25 November 2013
Proposal for a CEWG Demonstration Project by Médecins Sans Frontières (MSF) November 2013
Last updated 7 November 2013
Last updated 26 October 2013
Each year, the lives of two and a half million children are saved because they are protected against killer diseases through vaccination. Vaccinating with new vaccines should save many more lives, but high prices could prevent this from happening.
Last updated 15 October 2013
The treatment of people infected with hepatitis C virus (HCV) in developing countries has long been neglected. Now, an abundance of new drugs in the pipeline is set to transform and simplify treatment of the disease with effective oral medicines. But potentially sky-high prices – together with a lack of political commitment to confront the real burden of the HCV pandemic and overcome access barriers – threaten to prevent these promising medicines from reaching people who need them in developing countries.
Last updated 15 July 2013
Cytomegalovirus retinitis (CMVR) is a neglected opportunistic disease, largely undiagnosed and untreated, that claims the sight of thousands of people living with HIV/AIDS in developing countries each year.
In this briefing document, MSF calls for action at both international and national levels to address current shortcomings in the diagnosis and treatment of cytomegalovirus retinitis (CMVR). CMVR is a preventable disease caused by a virus (cytomegalovirus or CMV) that attacks the retina of the eye in patients with suppressed immune systems, specifically those infected with HIV. If untreated, the disease can lead to total and irreversible blindness.
Last updated 23 May 2013